5. Conclusion
cough, myalgia, fatigue
This double-blind, randomized clinical trial suggests that prescribing nanomicelles containing curcumin to patients hospitalized with mild-to-moderate COVID-19 can improve inflammatory symptoms such as cough, fatigue, and myalgia. Also, nanocurcumin reduced the demand and time of oxygen therapy and improved blood O